This test is most useful if any of these apply to you.
Most people never picture mold when they think about a healthy diet, but if you eat grains, nuts, spices, or dairy, small amounts of a fungal toxin are almost certainly passing through your body. This test catches the fingerprint that toxin leaves in your urine.
That matters because the parent toxin is one of the most potent liver carcinogens known, and the amount in your urine tracks what you have eaten in just the last day or two. A high reading is a prompt to look at your food now, not years down the line.
AFM1 (aflatoxin M1) is a small breakdown product of aflatoxin B1 (AFB1), a toxin made by molds that grow on crops like maize, peanuts, cereals, and spices. When you eat food carrying AFB1, your liver processes it, and one of the products is AFM1, which your body then clears into urine and, in nursing mothers, breast milk.
Because AFM1 only appears after you have been exposed to AFB1, measuring it in urine answers one question clearly: how much of this toxin recently entered your body. It is an exposure marker, not a readout of an organ working well or poorly. This is also a research-grade measurement. There are no standardized clinical cutoffs for a personal urine level, so a single number is best read as a rough gauge of recent intake rather than a verdict.
The reason aflatoxin is taken so seriously is its link to liver cancer. AFB1 is classified as a definite human carcinogen, the top hazard category used by the International Agency for Research on Cancer (IARC). AFM1 was once rated only a possible human carcinogen, but in 2012 IARC evaluated the aflatoxins as a group, including AFM1, and placed them all in that same top category. Even so, laboratory work puts AFM1's own potency at roughly 2 to 20 percent of AFB1. In people, the clearest danger signal comes from long-term studies of men who already carry the hepatitis B virus.
In a decade-long study of men carrying the hepatitis B surface antigen (a sign of chronic hepatitis B infection), those with detectable aflatoxin M1 in their urine were about 3.3 times as likely to develop liver cancer, and they showed more lasting signs of liver stress over time. A separate study in Taiwan found that the more aflatoxin biomarker a hepatitis B carrier had, the higher their liver cancer risk, and this rose further in people with certain inherited differences in detox genes (the GST family, which help the body clear toxins).
One reassurance for the general population: when researchers modeled how much liver cancer comes specifically from aflatoxin M1 in milk, the contribution was tiny, on the order of thousandths of a percent of cases worldwide. The strong risk sits where high exposure meets chronic hepatitis, not with occasional dietary traces alone.
Beyond the liver, one human study of 672 people found that those with type 2 diabetes had higher urinary aflatoxin M1 than those without, alongside more inflammation and more oxidative stress (chemical wear on cells). The researchers proposed that aflatoxin exposure may feed into the pathways that impair insulin. This is an early, association-only finding, not proof that the toxin causes diabetes, but it is a reason the marker is drawing interest beyond cancer.
This is the single most important thing to understand about a urine result. Aflatoxin M1 is short-lived. Human studies describe it as a marker of exposure over the previous 1 to 3 days, with some work narrowing the clearest window to the preceding 24 hours. Your level today largely reflects what you ate over the last couple of days, not your cumulative exposure across years.
That has two consequences. First, the number can swing day to day with your diet and how hydrated you are. Second, if you want a picture of long-term exposure, this is the wrong tool. Longer-lived blood markers, such as aflatoxin bound to albumin (a blood protein with a half-life of about 20 days), capture a wider window. Urine AFM1 shines at answering a narrower, more actionable question: am I being exposed right now?
Because a single urine level is a snapshot tied to your recent meals, one number in isolation can mislead. A low result the morning after a few careful days does not prove you are never exposed, and a high result after one contaminated meal does not mean chronic danger. The value comes from a pattern.
Get a baseline, then retest after you have made deliberate changes to your diet or food sourcing, in roughly 3 to 6 months, and periodically thereafter. If repeated readings stay detectable or high across different weeks, that consistency is far more meaningful than any single spike. Tracking the trend is also the only way to know whether a change you made actually lowered your exposure, since the marker responds to recent intake within days.
A detectable or high level is not a diagnosis; it is a lead to follow. The first step is your kitchen: aflatoxin concentrates in poorly stored grains, nuts, corn, peanut products, dried fruit, and spices, especially items kept warm and humid or held past their prime. Retesting after tightening your food sources tells you whether the exposure was a one-off or ongoing.
Combine the result with context rather than reading it alone. If you carry chronic hepatitis B or C, a repeatedly elevated level is a stronger reason to stay current with liver monitoring, and this is a conversation worth having with a hepatologist (a liver specialist). Pairing this marker with liver enzymes (ALT and AST, which rise when liver cells are stressed) and, where relevant, a liver cancer blood marker gives a fuller picture than the toxin alone. Persistent elevation plus abnormal liver labs warrants a proper workup rather than watchful waiting.
Evidence-backed interventions that affect your AFM1 level
Aflatoxin M1 is best interpreted alongside these tests.
Aflatoxin M1 is included in these pre-built panels.